{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:28:33Z","timestamp":1778898513110,"version":"3.51.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005310","name":"TAU | Claire and Am\u00e9d\u00e9e Maratier Institute for the Study of Blindness and Visual Disorders, Tel Aviv University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005310","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1038\/s41433-019-0614-9","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T15:14:36Z","timestamp":1570720476000},"page":"954-959","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["B-cell related biomarkers associated with severity of the first demyelinating event of acute optic neuritis"],"prefix":"10.1038","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6315-6908","authenticated-orcid":false,"given":"Asaf","family":"Achiron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5634-0432","authenticated-orcid":false,"given":"Idan","family":"Hecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lena","family":"Abayev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liron","family":"Naftali Ben Haim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Gurevich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,10]]},"reference":[{"key":"614_CR1","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/eye.2011.81","volume":"25","author":"D Pau","year":"2011","unstructured":"Pau D, Al Zubidi N, Yalamanchili S, Plant GT, Lee AG. Optic neuritis. Eye. 2011;25:833\u201342.","journal-title":"Eye"},{"key":"614_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/1756285611398702","volume":"4","author":"E Voss","year":"2011","unstructured":"Voss E, Raab P, Trebst C, Stangel M. Clinical approach to optic neuritis: pitfalls, red flags and differential diagnosis. Ther Adv Neurol Disord. 2011;4:123\u201334.","journal-title":"Ther Adv Neurol Disord"},{"key":"614_CR3","doi-asserted-by":"crossref","unstructured":"Kaur P, Bennett JL. Optic neuritis and the neuro\u2010ophthalmology of multiple sclerosis. Int Rev Neurobiol. 2007,79:633\u201363.","DOI":"10.1016\/S0074-7742(07)79028-1"},{"key":"614_CR4","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1155\/2013\/484959","volume":"35","author":"A Gajofatto","year":"2013","unstructured":"Gajofatto A, Calabrese M, Benedetti MD, Monaco S. Clinical, MRI, and CSF markers of disability progression in multiple sclerosis. Dis Markers. 2013;35:687\u201399.","journal-title":"Dis Markers"},{"key":"614_CR5","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1167\/iovs.14-15408","volume":"56","author":"A Feldman","year":"2015","unstructured":"Feldman A, Gurevich M, Huna-Baron R, Achiron A. The role of B cells in the early onset of the first demyelinating event of acute optic neuritis. Investig Ophthalmol Vis Sci. 2015;56:1349\u201356.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"614_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1196\/annals.1381.017","volume":"1107","author":"A Achiron","year":"2007","unstructured":"Achiron A, Feldman A, Mandel M, Gurevich M. Impaired expression of peripheral blood apoptotic-related gene transcripts in acute multiple sclerosis relapse. Ann N Y Acad Sci. 2007;1107:155\u201367.","journal-title":"Ann N Y Acad Sci"},{"key":"614_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.visres.2013.05.004","volume":"90","author":"IL Bailey","year":"2013","unstructured":"Bailey IL, Lovie-Kitchin JE. Visual acuity testing. From the laboratory to the clinic. Vis Res. 2013;90:2\u20139.","journal-title":"Vis Res"},{"key":"614_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/1756285613488434","volume":"6","author":"HF Harbo","year":"2013","unstructured":"Harbo HF, Gold R, Tintor\u00e9 M. Sex and gender issues in multiple sclerosis. Ther Adv Neurol Disord. 2013;6:237\u201348.","journal-title":"Ther Adv Neurol Disord"},{"key":"614_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/08916934.2017.1281914","volume":"50","author":"H Wekerle","year":"2017","unstructured":"Wekerle H. B cells in multiple sclerosis. Autoimmunity. 2017;50:57\u201360.","journal-title":"Autoimmunity"},{"key":"614_CR10","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1212\/WNL.0b013e318249f6f0","volume":"78","author":"G Disanto","year":"2012","unstructured":"Disanto G, Morahan JM, Barnett MH, Giovannoni G, Ramagopalan SV. The evidence for a role of B cells in multiple sclerosis. Neurology. 2012;78:823\u201332.","journal-title":"Neurology"},{"key":"614_CR11","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.4049\/jimmunol.1302672","volume":"192","author":"IR Hardy","year":"2014","unstructured":"Hardy IR, Anceriz N, Rousseau F, Seefeldt MB, Hatterer E, Irla M, et al. Anti-CD79 antibody induces B cell anergy that protects against autoimmunity. J Immunol. 2014;192:1641\u201350.","journal-title":"J Immunol"},{"key":"614_CR12","doi-asserted-by":"publisher","unstructured":"Hoffman L, Gore L. Blinatumomab, a Bi-specific anti-CD19\/CD3 BiTE\u00ae antibody for the treatment of acute lymphoblastic leukemia: perspectives and current pediatric applications. Front Oncol. 2014;4:63. \nhttps:\/\/doi.org\/10.3389\/fonc.2014.00063\n\n.","DOI":"10.3389\/fonc.2014.00063"},{"key":"614_CR13","first-page":"143","volume":"4","author":"F Naddafi","year":"2015","unstructured":"Naddafi F, Davami F. Anti-CD19 monoclonal antibodies: a new approach to lymphoma therapy. Int J Mol Cell Med. 2015;4:143\u201351.","journal-title":"Int J Mol Cell Med"},{"key":"614_CR14","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1001\/jamaneurol.2017.4011","volume":"75","author":"M Granqvist","year":"2018","unstructured":"Granqvist M, Boremalm M, Poorghobad A, et al. Comparative effectiveness of rituximab and other initial treatment choices for multiple sclerosis. JAMA Neurol. 2018;75:320\u20137.","journal-title":"JAMA Neurol"},{"key":"614_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1474-4422(17)30048-0","volume":"16","author":"R Hohlfeld","year":"2017","unstructured":"Hohlfeld R, Meinl E. Ocrelizumab in multiple sclerosis: markers and mechanisms. Lancet Neurol. 2017;16:259\u201361.","journal-title":"Lancet Neurol"},{"key":"614_CR16","doi-asserted-by":"publisher","first-page":"e1000113","DOI":"10.1371\/journal.pmed.1000113","volume":"6","author":"R Shechter","year":"2009","unstructured":"Shechter R, London A, Varol C, Raposo C, Cusimano M, Yovel G, et al. Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med. 2009;6:e1000113.","journal-title":"PLoS Med"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41433-019-0614-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-019-0614-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-019-0614-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:08:36Z","timestamp":1684616916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-019-0614-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,10]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["614"],"URL":"https:\/\/doi.org\/10.1038\/s41433-019-0614-9","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,10]]},"assertion":[{"value":"22 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}